This inventor holds 1 USPTO granted patent. Top assignee: Max-Delbru/ Ck-Centrum. Active years: 1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996
Title: The Innovations of Eckart Matthes
Introduction
Eckart Matthes is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of antiviral compounds, particularly through his innovative research and patents. His work focuses on the development of nucleoside compounds that exhibit antiviral activity.
Latest Patents
Eckart Matthes holds a patent for "2',3'-dideoxynucleoside pyrimidine compounds and carbocyclic analogs." This patent discloses compounds that are expected to exhibit antiviral activity, recognized for their potential in combating viral infections. The specific compounds include 2',3'-dideoxynucleoside pyrimidine compounds and 2-thiothymidine carbocyclic derivatives.
Career Highlights
Throughout his career, Matthes has been associated with Max-Delbrück-Centrum, where he has contributed to groundbreaking research in the field of virology. His work has led to advancements in the understanding and treatment of viral diseases.
Collaborations
Eckart Matthes has collaborated with esteemed colleagues such as Hans A. Rosenthal and Dieter Scholz. These collaborations have further enriched his research and contributed to the development of innovative antiviral compounds.
Conclusion
Eckart Matthes is a prominent figure in the field of antiviral research, with a patent that highlights his innovative contributions. His work continues to pave the way for advancements in the treatment of viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile